Three independent discounted-cash-flow-style models value Chemed Corporation every trading day. 1 of 3 currently price CHE above its market price.
| Free Cash Flow model | $-1,349.85 |
| Excess Profit model | $-1,327.58 |
| Residual Earnings model | $744.78 |
| Dividend Discount model | $129.02 |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +21.4% |
| Net debt / EBITDA | 0.6× |
| Gross margin | +32.5% |
| Revenue CAGR | +5.8% |
| Cash conversion | 1.5× |
| Dividend yield | +0.5% |
| Buyback yield | +4.2% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open CHE in StockKitty